We are international
Donate
TEXT SIZE   


Lethal and bortezomib-sensitizing targets in myeloma identified by genome-scale RNAi Screening
By Rodger E. Tiedemann, PhD
XIIth International Myeloma Workshop in Washington, DC
Rodger E. Tiedemann, PhD
Mayo Clinic
Scottsdale, Arizona
02.23.09



XIIth International Myeloma Workshop in Washington, DC - On demand Only
Session: Clinical - Basic Biology - Research
Chairs: Herve Avet-Loiseau, M.D., John Shaughnessy, M.D.

February 27, 2009, 13:30 - 13:45 Eastern Standard Time


Lethal and bortezomib-sensitizing targets in myeloma identified by genome-scale RNAi Screening
Dr. Rodger Tiedemann
Mayo Clinic, Scottsdale, AZ

 


Back to the Meeting Index


 related articles